RPg Family Wealth Advisory’s Virtus Biotech ETF BBP Stock Holding History

RPg Family Wealth Advisory’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-91,103	Closed	-$3.74M	–	292
2019 Q2	$3.74M	Buy	91,103 +1,207	+1%	+$49.7K	2.22%	16
2019 Q1	$4.03M	Buy	+89,896	New	+$3.77M	2.38%	14

Other funds holding BBP

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SMG

Smart Money Group Eastland, Texas $390M AUM 21.29% 1-Year Est. Return

FAIM

Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

AWCI

Alpine Woods Capital Investors Purchase, New York $417M AUM 26.83% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

RPg Family Wealth Advisory's BBP Position: Q3 2019 in Review

RPg Family Wealth Advisory sold out of Virtus Biotech ETF (BBP) in Q3 2019, closing a stake of 91,103 shares — an estimated $3.74M sold.

RPg Family Wealth Advisory first reported a position in BBP in Q1 2019 and held it in 2 quarters. The position peaked at $4.03M in Q1 2019. 15 funds tracked by Wall St. Rank hold BBP as of Q3 2019.

RPg Family Wealth Advisory reported no remaining Virtus Biotech ETF position as of Q3 2019 after selling out during the quarter.
RPg Family Wealth Advisory sold 91,103 Virtus Biotech ETF shares in Q3 2019, an estimated $3.74M.
RPg Family Wealth Advisory first reported a position in Virtus Biotech ETF in Q1 2019 and held it in 2 quarters.
RPg Family Wealth Advisory's Virtus Biotech ETF position peaked at $4.03M in Q1 2019.
15 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2019.

Based on RPg Family Wealth Advisory's 13F filing for Q3 2019, filed 12 Nov 2019.